PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration

Mayur Choudhary, Jin dong Ding, Xiaoping Qi, Michael E. Boulton, Pei Li Yao, Jeffrey Maurice Peters, Goldis Malek

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) is a nuclear receptor that regulates differentiation, inflammation, lipid metabolism, extracellular matrix remodeling, and angiogenesis in multiple tissues. These pathways are also central to the pathogenesis of age-related macular degeneration (AMD), the leading cause of vision loss globally. With the goal of identifying signaling pathways that may be important in the development of AMD, we investigated the impact of PPARβ/δ activation on ocular tissues affected in the disease. PPARβ/δ is expressed and can be activated in AMD vulnerable cells, including retinal pigment epithelial (RPE) and choroidal endothelial cells. Further, PPARβ/δ knockdown modulates AMD-related pathways selectively. Specifically, genetic ablation of Pparβ/δ in aged mice resulted in exacerbation of several phenotypic features of early dry AMD, but attenuation of experimentally induced choroidal neovascular (CNV) lesions. Antagonizing PPARβ/δ in both in vitro angiogenesis assays and in the in vivo experimentally induced CNV model, inhibited angiogenesis and angiogenic pathways, while ligand activation of PPARβ/δ, in vitro, decreased RPE lipid accumulation, characteristic of dry AMD. This study demonstrates for the first time, selective regulation of a nuclear receptor in the eye and establishes that selective targeting of PPARβ/δ may be a suitable strategy for treatment of different clinical sub-types of AMD.

Original languageEnglish (US)
Pages (from-to)1952-1978
Number of pages27
JournalAging
Volume8
Issue number9
DOIs
StatePublished - Jan 1 2016

Fingerprint

Peroxisome Proliferator-Activated Receptors
Macular Degeneration
Retinal Pigments
Cytoplasmic and Nuclear Receptors
Lipid Metabolism
Extracellular Matrix
Endothelial Cells
Ligands
Inflammation
Lipids

All Science Journal Classification (ASJC) codes

  • Aging
  • Cell Biology

Cite this

Choudhary, M., Ding, J. D., Qi, X., Boulton, M. E., Yao, P. L., Peters, J. M., & Malek, G. (2016). PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration. Aging, 8(9), 1952-1978. https://doi.org/10.18632/aging.101031
Choudhary, Mayur ; Ding, Jin dong ; Qi, Xiaoping ; Boulton, Michael E. ; Yao, Pei Li ; Peters, Jeffrey Maurice ; Malek, Goldis. / PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration. In: Aging. 2016 ; Vol. 8, No. 9. pp. 1952-1978.
@article{defe8b1b41794c5ab186f998a3061d57,
title = "PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration",
abstract = "Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) is a nuclear receptor that regulates differentiation, inflammation, lipid metabolism, extracellular matrix remodeling, and angiogenesis in multiple tissues. These pathways are also central to the pathogenesis of age-related macular degeneration (AMD), the leading cause of vision loss globally. With the goal of identifying signaling pathways that may be important in the development of AMD, we investigated the impact of PPARβ/δ activation on ocular tissues affected in the disease. PPARβ/δ is expressed and can be activated in AMD vulnerable cells, including retinal pigment epithelial (RPE) and choroidal endothelial cells. Further, PPARβ/δ knockdown modulates AMD-related pathways selectively. Specifically, genetic ablation of Pparβ/δ in aged mice resulted in exacerbation of several phenotypic features of early dry AMD, but attenuation of experimentally induced choroidal neovascular (CNV) lesions. Antagonizing PPARβ/δ in both in vitro angiogenesis assays and in the in vivo experimentally induced CNV model, inhibited angiogenesis and angiogenic pathways, while ligand activation of PPARβ/δ, in vitro, decreased RPE lipid accumulation, characteristic of dry AMD. This study demonstrates for the first time, selective regulation of a nuclear receptor in the eye and establishes that selective targeting of PPARβ/δ may be a suitable strategy for treatment of different clinical sub-types of AMD.",
author = "Mayur Choudhary and Ding, {Jin dong} and Xiaoping Qi and Boulton, {Michael E.} and Yao, {Pei Li} and Peters, {Jeffrey Maurice} and Goldis Malek",
year = "2016",
month = "1",
day = "1",
doi = "10.18632/aging.101031",
language = "English (US)",
volume = "8",
pages = "1952--1978",
journal = "Aging",
issn = "0002-0966",
publisher = "US Administration on Aging",
number = "9",

}

Choudhary, M, Ding, JD, Qi, X, Boulton, ME, Yao, PL, Peters, JM & Malek, G 2016, 'PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration', Aging, vol. 8, no. 9, pp. 1952-1978. https://doi.org/10.18632/aging.101031

PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration. / Choudhary, Mayur; Ding, Jin dong; Qi, Xiaoping; Boulton, Michael E.; Yao, Pei Li; Peters, Jeffrey Maurice; Malek, Goldis.

In: Aging, Vol. 8, No. 9, 01.01.2016, p. 1952-1978.

Research output: Contribution to journalArticle

TY - JOUR

T1 - PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration

AU - Choudhary, Mayur

AU - Ding, Jin dong

AU - Qi, Xiaoping

AU - Boulton, Michael E.

AU - Yao, Pei Li

AU - Peters, Jeffrey Maurice

AU - Malek, Goldis

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) is a nuclear receptor that regulates differentiation, inflammation, lipid metabolism, extracellular matrix remodeling, and angiogenesis in multiple tissues. These pathways are also central to the pathogenesis of age-related macular degeneration (AMD), the leading cause of vision loss globally. With the goal of identifying signaling pathways that may be important in the development of AMD, we investigated the impact of PPARβ/δ activation on ocular tissues affected in the disease. PPARβ/δ is expressed and can be activated in AMD vulnerable cells, including retinal pigment epithelial (RPE) and choroidal endothelial cells. Further, PPARβ/δ knockdown modulates AMD-related pathways selectively. Specifically, genetic ablation of Pparβ/δ in aged mice resulted in exacerbation of several phenotypic features of early dry AMD, but attenuation of experimentally induced choroidal neovascular (CNV) lesions. Antagonizing PPARβ/δ in both in vitro angiogenesis assays and in the in vivo experimentally induced CNV model, inhibited angiogenesis and angiogenic pathways, while ligand activation of PPARβ/δ, in vitro, decreased RPE lipid accumulation, characteristic of dry AMD. This study demonstrates for the first time, selective regulation of a nuclear receptor in the eye and establishes that selective targeting of PPARβ/δ may be a suitable strategy for treatment of different clinical sub-types of AMD.

AB - Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) is a nuclear receptor that regulates differentiation, inflammation, lipid metabolism, extracellular matrix remodeling, and angiogenesis in multiple tissues. These pathways are also central to the pathogenesis of age-related macular degeneration (AMD), the leading cause of vision loss globally. With the goal of identifying signaling pathways that may be important in the development of AMD, we investigated the impact of PPARβ/δ activation on ocular tissues affected in the disease. PPARβ/δ is expressed and can be activated in AMD vulnerable cells, including retinal pigment epithelial (RPE) and choroidal endothelial cells. Further, PPARβ/δ knockdown modulates AMD-related pathways selectively. Specifically, genetic ablation of Pparβ/δ in aged mice resulted in exacerbation of several phenotypic features of early dry AMD, but attenuation of experimentally induced choroidal neovascular (CNV) lesions. Antagonizing PPARβ/δ in both in vitro angiogenesis assays and in the in vivo experimentally induced CNV model, inhibited angiogenesis and angiogenic pathways, while ligand activation of PPARβ/δ, in vitro, decreased RPE lipid accumulation, characteristic of dry AMD. This study demonstrates for the first time, selective regulation of a nuclear receptor in the eye and establishes that selective targeting of PPARβ/δ may be a suitable strategy for treatment of different clinical sub-types of AMD.

UR - http://www.scopus.com/inward/record.url?scp=84991451252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991451252&partnerID=8YFLogxK

U2 - 10.18632/aging.101031

DO - 10.18632/aging.101031

M3 - Article

C2 - 27622388

AN - SCOPUS:84991451252

VL - 8

SP - 1952

EP - 1978

JO - Aging

JF - Aging

SN - 0002-0966

IS - 9

ER -